Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Combination Therapy With Cystagon and N-Acetylcysteine for INCL Patients

NCT00028262 is registered in ClinicalTrials.gov with Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) as lead sponsor.

NCT NCT00028262
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00028262 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Combination Therapy With Cystagon and N-Acetylcysteine for INCL Patients
Lead sponsor
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Phase
Phase 4
Overall status
Completed
Start date
February 28, 2001
Completion date
November 30, 2013
Enrollment
10 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

infantile neronal ceroid lipofuscinosis